Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 20 March 2013 | By Louise Zornoza,
Australia's Therapeutic Goods Administration (TGA) has posted new guidance reclassifying joint replacements such as hip, knee and shoulder replacement devices.
Under the new guidance, applications to reclassify a joint replacement implant from Class IIb (medium-high risk medical devices) to Class III (high-risk medical devices) could require more than one application. A single Class IIb joint implant may have to be 'cloned' into multiple reclassification applications if:
Supporting information from the manufacturer, such as the design examination certificate and product information, may help distinguish whether the transitioning joint replacement implant is a different kind of medical device.
All hip, knee and shoulder joint implants were reclassified as high-risk devices in August 2012. A two-year transition period was provided for companies to complete conformity assessment procedures (Design Examination) to ensure that their implants meet the requirements for Class III medical devices before submitting reclassification applications.
Tags: Knee, hip, australia, medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.